about
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...
Read More
28.44
0.37
(1.32%)
505.6K
XNAS Volume
XNAS 10 Mar, 2026 4:00 PM (EDT)
Not Eligible
Affordable Valuation
Technically Neutral
Rigel Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..